Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial
Jessica E. Manning, Fabiano Oliveira, Iliano V. Coutinho-Abreu, et al.
The Lancet (2020) Vol. 395, Iss. 10242, pp. 1998-2007
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Advances in Infectious Disease Vaccine Adjuvants
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1120-1120
Open Access | Times Cited: 74
Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 22
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development
Julie Ostrowsky, Leah C. Katzelnick, Nigel Bourne, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 3
Vector-Borne Viral Diseases as a Current Threat for Human and Animal Health—One Health Perspective
Wojciech Socha, Małgorzata Kwaśnik, Magdalena Larska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3026-3026
Open Access | Times Cited: 66
Malaria: influence of Anopheles mosquito saliva on Plasmodium infection
Gunjan Arora, Yu-Min Chuang, Photini Sinnis, et al.
Trends in Immunology (2023) Vol. 44, Iss. 4, pp. 256-265
Open Access | Times Cited: 26
Unraveling the Molecular Mechanisms of Mosquito Salivary Proteins: New Frontiers in Disease Transmission and Control
Jiayin Guo, Xiaoe He, Jianli Tao, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 82-82
Open Access | Times Cited: 1
Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
Navneet Arora, Lokhesh C Anbalagan, Ashok Kumar Pannu
Risk Management and Healthcare Policy (2021) Vol. Volume 14, pp. 1033-1039
Open Access | Times Cited: 53
Aedes Mosquito Salivary Components and Their Effect on the Immune Response to Arboviruses
David Guerrero, Tineke Cantaert, Dorothée Missé
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 50
Understanding pathogen survival and transmission by arthropod vectors to prevent human disease
Carolina Barillas‐Mury, José M. C. Ribeiro, Jesús G. Valenzuela
Science (2022) Vol. 377, Iss. 6614
Closed Access | Times Cited: 37
An Aedes–Anopheles Vaccine Candidate Supplemented with BCG Epitopes Against the Aedes and Anopheles Genera to Overcome Hypersensitivity to Mosquito Bites
Muhammad Naveed, Urooj Ali, Tariq Aziz, et al.
Acta Parasitologica (2024) Vol. 69, Iss. 1, pp. 483-504
Closed Access | Times Cited: 8
20-Hydroxyecdysone (20E) signaling as a promising target for the chemical control of malaria vectors
Elodie Ekoka, Surina Maharaj, Luisa Nardini, et al.
Parasites & Vectors (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Update on mosquito bite reaction: Itch and hypersensitivity, pathophysiology, prevention, and treatment
Ashley Vander Does, Angelina Labib, Gil Yosipovitch
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Evaluation of cutaneous immune response in a controlled human in vivo model of mosquito bites
David Guerrero, Hoa Thi My Vo, Chanthap Lon, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
The Bm86 Discovery: A Revolution in the Development of Anti-Tick Vaccines
Alina Rodríguez-Mallón
Pathogens (2023) Vol. 12, Iss. 2, pp. 231-231
Open Access | Times Cited: 14
Monoclonal antibodies for malaria prevention
Maya Aleshnick, Melina Florez-Cuadros, Thomas Martinson, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1810-1821
Open Access | Times Cited: 21
Vector control in China, from malaria endemic to elimination and challenges ahead
Xinyu Feng, Jun Feng, Li Zhang, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
Kenneth C. Elliott, Joseph J. Mattapallil
Pathogens (2024) Vol. 13, Iss. 2, pp. 177-177
Open Access | Times Cited: 4
Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines
Alejandro Marín-López, Hamidah Raduwan, Tse-Yu Chen, et al.
Pathogens (2023) Vol. 12, Iss. 3, pp. 371-371
Open Access | Times Cited: 10
Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
Zhuang Li, Yilu Zhao, Ling Yang, et al.
Decoding Infection and Transmission (2024) Vol. 2, pp. 100026-100026
Open Access | Times Cited: 3
The ecological significance of arthropod vectors of plant, animal, and human pathogens
Thierry Léfèvre, Nicolas Sauvion, Rodrigo P. P. Almeida, et al.
Trends in Parasitology (2022) Vol. 38, Iss. 5, pp. 404-418
Open Access | Times Cited: 15
Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol
Rodrigo Ochoa, Victória Alves Santos Lunardelli, Daniela Santoro Rosa, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial
DeAnna Friedman-Klabanoff, Megan Birkhold, Mara Short, et al.
EBioMedicine (2022) Vol. 86, pp. 104375-104375
Open Access | Times Cited: 15
Protective Efficacy of Multiple Epitope-Based Vaccine against Hyalomma anatolicum, Vector of Theileria annulata and Crimean–Congo Hemorrhagic Fever Virus
Abhijit Nandi, Manisha, Vandana Solanki, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 881-881
Open Access | Times Cited: 8
Novel approaches for the rapid development of rationally designed arbovirus vaccines
Joyce W. M. van Bree, Imke Visser, Jo M. Duyvestyn, et al.
One Health (2023) Vol. 16, pp. 100565-100565
Open Access | Times Cited: 8
Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia
Jessica E. Manning, Sophana Chea, Daniel M. Parker, et al.
The Journal of Infectious Diseases (2021) Vol. 226, Iss. 8, pp. 1327-1337
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top